215
Views
5
CrossRef citations to date
0
Altmetric
Articles

Combined oral isotretinoin and Candida antigen versus either agent alone in the treatment of plane warts

, &
Pages 342-347 | Received 06 Feb 2020, Accepted 26 Mar 2020, Published online: 22 Apr 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Anon Paichitrojjana & Anand Paichitrojjana. (2023) Oral Isotretinoin and Its Uses in Dermatology: A Review. Drug Design, Development and Therapy 17, pages 2573-2591.
Read now

Articles from other publishers (4)

Ghada Farouk Mohammed, Mohammed Saleh Al‐Dhubaibi, Saleh Salem Bahaj & Ahmed Ibrahim Abd Elneam. (2022) Systemic immunotherapy for the treatment of warts: A literature review. Journal of Cosmetic Dermatology 21:11, pages 5532-5536.
Crossref
Ahmad Nofal, Mohamed M. Fawzy, Fatma Eldeeb & Esraa Elsayed Elhawary. (2022) Oral isotretinoin versus acitretin in male patients with multiple recalcitrant common warts: A randomized, double‐blinded placebo‐control study. Journal of Cosmetic Dermatology 21:11, pages 5895-5901.
Crossref
Mohamed H. M. EL-Komy, Shahenda Gamal Shamma & Nermeen Ibrahim Bedair. (2022) The efficacy and safety of intralesional Candida vaccine versus topical diphencyproprobenone in immunotherapy of verruca vulgaris: A randomized comparative study. Archives of Dermatological Research 315:3, pages 583-591.
Crossref
Ahmad Nofal & Mohamed M. Fawzy. (2020) Low‐dose oral isotretinoin for the treatment of warts: A controversial issue. Dermatologic Therapy 33:6.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.